Archer-Daniels-Midland is projected to report Q1 2026 consensus revenue of $21.11 billion and EPS of $0.66, with its current $74.94 share price trading well above the average analyst price target of $64.40.
Investors are primarily focused on the stabilization of the Nutrition segment following recent accounting-related volatility and the operational return of the Decatur East facility. Supporting this, the Ag Services and Oilseeds segment remains a critical engine, with analysts expecting $16.58 billion in revenue despite ongoing pressure on global crush margins. Market participants will also closely scrutinize management's full-year 2026 guidance of $3.60 to $4.25 per share for any revisions based on shifting biofuel policies and commodity demand.